The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2015
Filed:
Nov. 23, 2011
Applicant:
Kenichiro Hasumi, Tokyo, JP;
Inventor:
Kenichiro Hasumi, Tokyo, JP;
Assignee:
Hasumi International Research Foundation, Washington, DC (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/12 (2006.01); A61K 39/39 (2006.01); A61K 35/15 (2015.01); A61K 31/739 (2006.01); A61K 35/12 (2015.01); A61K 36/06 (2006.01); A61K 36/07 (2006.01); A61K 36/074 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/739 (2013.01); A61K 35/12 (2013.01); A61K 35/15 (2013.01); A61K 36/06 (2013.01); A61K 36/07 (2013.01); A61K 36/074 (2013.01); A61K 38/193 (2013.01); A61K 38/2026 (2013.01); A61K 39/0011 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/55522 (2013.01);
Abstract
The invention relates to a method of treating tumor cells within a patient wherein immature dendritic cells developed from the patient's monocyte cells and a lymphocyte cultured medium (LCM) adjuvant are introduced into the patient directly into the patient's tumor cells. The immature dendritic cells and LCM adjuvant combine with the antigens in the tumor cells to form a cancer vaccine, thereby immediately treating the tumor cells of the patient. The invention also provides a precursor treatment step of treating the patient with radiation therapy or a chemotherapy regimen.